Remifentanil target-controlled infusion with intranasal dexmedetomidine for vitreoretinal procedures: a randomized controlled trial

AIM: To evaluate the consumption of remifentanil (as a primary end-point), analgesia, sedation, hemodynamics, respiratory effects, and surgeon and patient satisfaction (as a secondary end-point) with dexmedetomidine sedation compared with those of remifentanil sedation in patients undergoing vitreor...

Descripción completa

Detalles Bibliográficos
Autores principales: Potočnik, Iztok, Andjelkovič-Juvan, Lea, Hostnik, Andrej, Markovič-Božič, Jasmina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Croatian Medical Schools 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8275941/
https://www.ncbi.nlm.nih.gov/pubmed/34212560
http://dx.doi.org/10.3325/cmj.2021.62.233

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8275941/
https://www.ncbi.nlm.nih.gov/pubmed/34212560
http://dx.doi.org/10.3325/cmj.2021.62.233

Ejemplares similares